Area of research
Pharmacology · Experimental and Cognitive Psychology
Research interest
Research interests include Treatment of Major Depression, Sleep and related disorders, Mental Health Treatment and Access, and Sleep and Wakefulness Research.
Psychological intervention in individuals with subthreshold depression: individual participant data meta-analysis of treatment effects and moderators
Sex differences in plasma proteomic markers in late-life depression
Relationship between Patient Health Questionnaire (PHQ-9) and Montgomery-Asberg Depression Rating Scale (MADRS) total scores in older adults with major depressive disorder: An analysis of the OPTIMUM clinical trial
<scp>CYP2D6</scp> Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression
Randomized Clinical Trial of the Four Supports Intervention for Surrogate Decision-Makers in Intensive Care Units
From Alert Child to Sleepy Adolescent: Age Trends in Chronotype, Social Jetlag, and Sleep Problems in Youth with Autism.
CYP2D6 Phenotype Influences Pharmacokinetic Parameters of Venlafaxine: Results from a Population Pharmacokinetic Model in Older Adults with Depression.
Depression is Associated with Treatment Response Trajectories in Adults with Prolonged Grief Disorder: A Machine Learning Analysis
Antidepressant Augmentation versus Switch in Treatment-Resistant Geriatric Depression
Major depression, physical health and molecular senescence markers abnormalities
Towards Outcome-Driven Patient Subgroups: A Machine Learning Analysis Across Six Depression Treatment Studies
Life-Course Brain Health as a Determinant of Late-Life Mental Health: American Association for Geriatric Psychiatry Expert Panel Recommendations
Change in patient‐centered outcomes of psychological well‐being, sleep, and suicidality following treatment with intravenous ketamine for late‐life treatment‐resistant depression
Mental health care for older adults: recent advances and new directions in clinical practice and research
Association of 24-Hour Activity Pattern Phenotypes With Depression Symptoms and Cognitive Performance in Aging
Late-Life Depression is Associated With Increased Levels of GDF-15, a Pro-Aging Mitokine
Association of Molecular Senescence Markers in Late-Life Depression With Clinical Characteristics and Treatment Outcome
Intravenous Ketamine for Late-Life Treatment-Resistant Depression: A Pilot Study of Tolerability, Safety, Clinical Benefits, and Effect on Cognition
Falls prediction using the nursing home minimum dataset
Venlafaxine XR treatment for older patients with major depressive disorder: decision trees for when to change treatment
Predicting Medication Nonadherence in Older Adults With Difficult-to-Treat Depression in the IRL-GRey Randomized Controlled Trial
Diversify Your Emotional Assets: The Association Between the Variety of Sources of Emotional Support and Thoughts of Death or Self-harm Among US Older Adults.
Identifying the Common Genetic Basis of Antidepressant Response
Universal depression prevention: An umbrella review of meta-analyses
The Effects of Gait Speed and Psychomotor Speed on Risk for Depression and Anxiety in Older Adults with Medical Comorbidities
Low-Dose Augmentation With Buprenorphine for Treatment-Resistant Depression: A Multisite Randomized Controlled Trial With Multimodal Assessment of Target Engagement
Older Adults and the Mental Health Effects of COVID-19
A Brain Capital Grand Strategy: toward economic reimagination
Pharmacogenetic Implications for Antidepressant Pharmacotherapy in Late-Life Depression: A Systematic Review of the Literature for Response, Pharmacokinetics and Adverse Drug Reactions
Post-Intensive Care Unit Care. A Qualitative Analysis of Patient Priorities and Implications for Redesign.